C. Wyndham-Thomas

发表

Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study.

P. Maes, S. Fieuws, W. Peetermans, 2020, The Lancet. Infectious diseases.

Prospective Serial FDG PET/CT During Treatment of Extrapulmonary Tuberculosis in HIV-Infected Patients: An Exploratory Study

S. De Wit, Camilo Garcia, Charlotte Martin, 2018, Clinical nuclear medicine.

assay for the detection of latent tuberculosis: the key role of effector memory 2

C. Locht, M. Libin, M. Loyens, 2014 .

Key Role of Effector Memory CD4+ T Lymphocytes in a Short-Incubation Heparin-Binding Hemagglutinin Gamma Interferon Release Assay for the Detection of Latent Tuberculosis

C. Locht, F. Mascart, M. Libin, 2014, Clinical and Vaccine Immunology.

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

V. Hutse, G. Muyldermans, S. Van Gucht, 2019, BMC Public Health.

Blood tolerogenic monocytes and low proportions of dendritic cell subpopulations are hallmarks of human tuberculosis

T. Giese, F. Mascart, M. Hites, 2018, Journal of leukocyte biology.

Response of Human Immunodeficiency Virus-Associated Cerebral Angiitis to the Combined Antiretroviral Therapy

G. Naeije, J. Cheron, N. Sadeghi, 2017, Front. Neurol..

Immune Activation by Mycobacterium tuberculosis in HIV-Infected and -Uninfected Subjects

F. Mascart, M. Payen, C. Wyndham-Thomas, 2017, Journal of acquired immune deficiency syndromes.

COVID-19 Vaccine effectiveness against symptomatic infection and hospitalization in Belgium, July 2021-April 2022

R. Brondeel, J. van Loenhout, L. Catteau, 2022, medRxiv.

Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021

R. Brondeel, H. Van Oyen, R. Mahieu, 2022, Vaccine.

Implementation of latent tuberculosis screening in HIV care centres: evaluation in a low tuberculosis incidence setting

F. Mascart, C. Wyndham-Thomas, K. Schepers, 2015, Epidemiology and Infection.

Rapid establishment of a national surveillance of COVID-19 hospitalizations in Belgium

N. Bossuyt, T. Lernout, J. Deblonde, 2020, Archives of Public Health.

Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities

C. Wyndham-Thomas, Ana Hoxha, D. Dubourg, 2020, The Lancet Infectious Diseases.

Immunisation of migrants in EU/EEA countries: Policies and practices.

H. D. de Melker, V. Saliba, D. Levy-bruhl, 2019, Vaccine.

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants

E. Goetghebeur, M. Montourcy, H. Van Oyen, 2020, International Journal of Antimicrobial Agents.

BARRIERS TO LIVER TRANSPLANTATION IN HIV INFECTED PATIENTS

S. De Wit, C. Wyndham-Thomas, J. Mulkay, 2013, Acta clinica Belgica.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Who Have Sex With Men: Diagnostic Accuracy of Nucleic Acid Amplification Test on Pooled Urine, Anorectal, and Pharyngeal Specimens

I. Montesinos, C. Wyndham-Thomas, M. Delforge, 2017, Sexually transmitted diseases.

Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium

R. Brondeel, H. Van Oyen, L. Catteau, 2022, Viruses.

Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022

R. Brondeel, H. Van Oyen, R. Mahieu, 2023, Vaccine.

Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients

E. André, R. Brondeel, B. Serrien, 2021, Archives of Public Health.

2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients

F. Mascart, C. Wyndham-Thomas, J. Goffard, 2018, Acta clinica Belgica.

High number of hospitalisations and non-classical presentations: lessons learned from a measles outbreak in 2017, Belgium

V. Hutse, T. Asikainen, C. Wyndham-Thomas, 2020, Epidemiology and Infection.

Incidence rate, predictors and outcomes of interruption of HIV care: nationwide results from the Belgian HIV cohort

J. Macq, S. De Wit, H. Van Oyen, 2020, HIV medicine.

Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021

H. Van Oyen, R. Mahieu, K. De Ridder, 2021, Vaccine.

[Cutaneous lesions in a 69-year-old woman].

C. Wyndham-Thomas, J. Bouaziz, R. Damade, 2017, La Revue de medecine interne.

COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022

R. Brondeel, L. Catteau, V. Stouten, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON®-TB Gold In-tube

C. Locht, F. Mascart, M. Libin, 2015, BMC Infectious Diseases.

Immunological Signatures Identifying Different Stages of Latent Mycobacterium tuberculosis Infection and Discriminating Latent from Active Tuberculosis in Humans

C. Locht, Mahavir Singh, F. Mascart, 2015 .